LU82105A1 - Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant - Google Patents

Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant Download PDF

Info

Publication number
LU82105A1
LU82105A1 LU82105A LU82105A LU82105A1 LU 82105 A1 LU82105 A1 LU 82105A1 LU 82105 A LU82105 A LU 82105A LU 82105 A LU82105 A LU 82105A LU 82105 A1 LU82105 A1 LU 82105A1
Authority
LU
Luxembourg
Prior art keywords
formula
fluoro
trans
pyrido
hexahydro
Prior art date
Application number
LU82105A
Other languages
English (en)
French (fr)
Inventor
W Welch Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU82105A1 publication Critical patent/LU82105A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
LU82105A 1979-01-23 1980-01-22 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant LU82105A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US569879 1979-01-23
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (1)

Publication Number Publication Date
LU82105A1 true LU82105A1 (fr) 1980-08-08

Family

ID=21717248

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82105A LU82105A1 (fr) 1979-01-23 1980-01-22 Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant

Country Status (34)

Country Link
US (1) US4224329A (ko)
JP (4) JPS55100386A (ko)
KR (1) KR830001932A (ko)
AR (1) AR231291A1 (ko)
AT (1) AT376674B (ko)
AU (1) AU521986B2 (ko)
BE (1) BE881283A (ko)
CA (1) CA1144168A (ko)
CH (2) CH651040A5 (ko)
CS (4) CS221809B2 (ko)
DD (2) DD149071A5 (ko)
DE (1) DE3002367A1 (ko)
DK (1) DK25580A (ko)
EG (1) EG14767A (ko)
FI (1) FI800179A (ko)
FR (3) FR2447379A1 (ko)
GB (1) GB2041925B (ko)
GR (1) GR73567B (ko)
HU (3) HU184712B (ko)
IE (1) IE49500B1 (ko)
IL (1) IL59189A (ko)
IN (1) IN153300B (ko)
IT (1) IT1149927B (ko)
LU (1) LU82105A1 (ko)
NL (1) NL8000385A (ko)
NO (2) NO151895C (ko)
NZ (3) NZ197582A (ko)
PH (4) PH15736A (ko)
PL (4) PL120774B1 (ko)
PT (1) PT70724A (ko)
SE (3) SE441358B (ko)
SU (3) SU1168094A3 (ko)
YU (2) YU269379A (ko)
ZA (1) ZA796374B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (ko) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
SE8404555L (sv) 1984-09-11
SE8404555D0 (sv) 1984-09-11
SE441358B (sv) 1985-09-30
DD149071A5 (de) 1981-06-24
ATA33380A (de) 1984-05-15
NZ197582A (en) 1984-05-31
BE881283A (fr) 1980-07-22
IL59189A0 (en) 1980-05-30
SU1168094A3 (ru) 1985-07-15
SE8404554L (sv) 1984-09-11
AU5476580A (en) 1980-07-31
AU521986B2 (en) 1982-05-13
CS221806B2 (en) 1983-04-29
SE8404554D0 (sv) 1984-09-11
CS221807B2 (en) 1983-04-29
NO794317L (no) 1980-07-24
PL126867B1 (en) 1983-09-30
IT1149927B (it) 1986-12-10
NZ192175A (en) 1984-05-31
NO843041L (no) 1980-07-24
JPS5636486A (en) 1981-04-09
IL59189A (en) 1984-01-31
JPS5636487A (en) 1981-04-09
YU242183A (en) 1984-06-30
JPS5636475A (en) 1981-04-09
PT70724A (en) 1980-02-01
CS221809B2 (en) 1983-04-29
NO151895C (no) 1985-06-26
EG14767A (en) 1985-12-31
ZA796374B (en) 1980-11-26
FI800179A (fi) 1980-07-24
IT8019373A0 (it) 1980-01-22
PH17773A (en) 1984-12-11
PL126532B1 (en) 1983-08-31
FR2447379B1 (ko) 1983-08-19
FR2453174A1 (fr) 1980-10-31
CH651040A5 (fr) 1985-08-30
CA1144168A (en) 1983-04-05
PL120774B1 (en) 1982-03-31
SU1333239A3 (ru) 1987-08-23
JPS5855151B2 (ja) 1983-12-08
GR73567B (ko) 1984-03-16
GB2041925B (en) 1982-10-20
SU1080746A3 (ru) 1984-03-15
CH648314A5 (fr) 1985-03-15
PH15736A (en) 1983-03-18
YU269379A (en) 1984-04-30
CS221808B2 (en) 1983-04-29
JPS5740151B2 (ko) 1982-08-25
DK25580A (da) 1980-07-24
JPS55100386A (en) 1980-07-31
NZ197581A (en) 1984-05-31
IE800121L (en) 1980-07-23
HU189174B (en) 1986-06-30
FR2447379A1 (fr) 1980-08-22
NO151895B (no) 1985-03-18
PL126032B1 (en) 1983-07-30
HU184712B (en) 1984-10-29
SE8000329L (sv) 1980-07-24
PH15072A (en) 1982-06-03
DD156369A5 (de) 1982-08-18
GB2041925A (en) 1980-09-17
PL221248A1 (ko) 1980-12-01
NL8000385A (nl) 1980-07-25
FR2453174B1 (ko) 1983-07-29
DE3002367A1 (de) 1980-07-24
IN153300B (ko) 1984-06-30
AR231291A1 (es) 1984-10-31
HU188201B (en) 1986-03-28
AT376674B (de) 1984-12-27
KR830001932A (ko) 1983-05-19
IE49500B1 (en) 1985-10-16
FR2453175A1 (fr) 1980-10-31
PH15086A (en) 1982-07-02
US4224329A (en) 1980-09-23
FR2453175B1 (ko) 1983-07-29

Similar Documents

Publication Publication Date Title
LU82105A1 (fr) Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant
EP1680421B1 (fr) Composes tricycliques comme inhibiteurs de transport de glycine
CA1213280A (fr) PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE 4-(1H- INDOL-3-YL) .alpha.-METHYL PIPERIDINE-1-ETHANOL ET DE LEURS SELS
CH644348A5 (fr) Amino-ethers oxydes, leur procede de preparation et medicament les contenant.
US4432993A (en) Method of treating obesity hyperglycemia, inflammation and platelet aggregation
FR2674849A1 (fr) Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
FR2533564A1 (fr) Derives de la piperazine presentant une activite anticholinergique et/ou antihistaminique
EP0140359B1 (en) Morpholine derivatives
CH661046A5 (fr) Derives de benzodioxinopyrrole et procedes de preparation.
CA2178302C (fr) Nouveaux derives de l'indole, de l'indazole et du benzisoxazole,leur pr ocede de preparation et les compositions pharmaceutiques qui les contiennent
BE1009852A3 (fr) Derives 1-[2(vinyl-substitues)]-3-4-dihydro-5h-2,3-benzodiazepine.
CA2249756C (fr) Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CH634321A5 (en) trans-5-Aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles, process for their preparation and pharmaceutical composition containing them
CH657362A5 (fr) Derives de l'oxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation.
FR2643634A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2713641A1 (fr) Dérivés de l'épi-épibatidine.
NO309649B1 (no) <alfa>-(substituerte alkylfenyl)-4-(hydroxydifenylmethyl)-1- piperidinbutanolderivater og deres anvendelse til fremstilling av antihistaminer, anti-allergimidler og bronchodilatorer
US4692465A (en) 2-phenylethylamine derivatives
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
US4252812A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
KR960007523B1 (ko) 4-아릴카르보닐-1-[(4-모르폴리닐)-저급-알킬]-1h-인돌, 그 제조 방법 및 이를 포함한 조성물
CH658786A5 (fr) Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.
EP1476433B1 (fr) Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
JPH02236A (ja) 選択的セロトニン摂取抑制剤